Tower Research Capital (TRC)’s MicroSectors FANG & Innovation -3x Inverse Leveraged ETN BERZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-56
Closed -$6.36K 5227
2025
Q2
$6.36K Buy
56
+48
+600% +$9.77K ﹤0.01% 4112
2025
Q1
$2.6K Buy
8
+3
+60% +$782 ﹤0.01% 4524
2024
Q4
$1.3K Buy
5
+4
+400% +$1.18K ﹤0.01% 5052
2024
Q3
$275 Sell
1
-2
-67% -$825 ﹤0.01% 5402
2024
Q2
$1.15K Hold
3
﹤0.01% 5195
2024
Q1
$1.52K Hold
3
﹤0.01% 5253
2023
Q4
$2.28K Sell
3
-1
-25% -$1.14K ﹤0.01% 5242
2023
Q3
$6.45K Sell
4
-92
-96% -$128K ﹤0.01% 4596
2023
Q2
$142K Buy
96
+75
+357% +$176K ﹤0.01% 1797
2023
Q1
$55K Sell
21
-13
-38% -$54K ﹤0.01% 2397
2022
Q4
$244K Buy
34
+17
+100% +$121K 0.01% 1177
2022
Q3
$148K Buy
+17
New +$104K ﹤0.01% 2205

Other funds holding BERZ

Tower Research Capital (TRC)'s BERZ Position: Q3 2025 in Review

Tower Research Capital (TRC) sold out of MicroSectors FANG & Innovation -3x Inverse Leveraged ETN (BERZ) in Q3 2025, closing a stake of 56 shares — an estimated $6.36K sold.

Tower Research Capital (TRC) first reported a position in BERZ in Q3 2022 and held it in 12 quarters. The position peaked at $244K in Q4 2022. 3 funds tracked by Wall St. Rank hold BERZ as of Q3 2025.

  • Tower Research Capital (TRC) reported no remaining MicroSectors FANG & Innovation -3x Inverse Leveraged ETN position as of Q3 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 56 MicroSectors FANG & Innovation -3x Inverse Leveraged ETN shares in Q3 2025, an estimated $6.36K.
  • Tower Research Capital (TRC) first reported a position in MicroSectors FANG & Innovation -3x Inverse Leveraged ETN in Q3 2022 and held it in 12 quarters.
  • Tower Research Capital (TRC)'s MicroSectors FANG & Innovation -3x Inverse Leveraged ETN position peaked at $244K in Q4 2022.
  • 3 funds tracked by Wall St. Rank held MicroSectors FANG & Innovation -3x Inverse Leveraged ETN as of Q3 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2025, filed 14 Nov 2025.